Clinical Trial Update: Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF) [Phase 4]

View source ↗

Summary

A Phase 4 trial update for the OPTIMIZE-HF program investigating lifesaving treatment initiation in hospitalized heart failure patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: GlaxoSmithKline | Conditions: Heart Failure, Congestive | Phase 4 | Status: COMPLETED